Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

35.6%

26 terminated/withdrawn out of 73 trials

Success Rate

63.9%

-22.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

11%

5 of 46 completed trials have results

Key Signals

1 recruiting5 with results26 withdrawn

Enrollment Performance

Analytics

Phase 1
15(57.7%)
N/A
9(34.6%)
Early Phase 1
1(3.8%)
Phase 2
1(3.8%)
26Total
Phase 1(15)
N/A(9)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials
NCT01166854Recruiting

Characterization of Familial Myopathy and Paget Disease of Bone

Role: collaborator

NCT00544427Withdrawn

Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract

Role: collaborator

NCT01773551Withdrawn

Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response

Role: collaborator

NCT01775722Not ApplicableCompleted

Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment

Role: collaborator

NCT00667472Phase 1Withdrawn

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Role: collaborator

NCT02473874Withdrawn

Comparison Imaging System Between Spatially Modulated Quantitative Spectroscopy and Skin Spect Dermoscopy

Role: collaborator

NCT00540852Not ApplicableCompleted

Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy

Role: collaborator

NCT01924273Phase 1Completed

Novel Treatment for Port Wine Stain Birthmarks

Role: collaborator

NCT01981902Withdrawn

Non-Invasive Optical Spectroscopic Methods for Dehydration Identification in Marathon Trainees

Role: collaborator

NCT01263405Completed

Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic Imaging

Role: collaborator

NCT00830466Phase 1Completed

A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Role: collaborator

NCT02410980Early Phase 1Completed

Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies

Role: collaborator

NCT01166919Phase 1Withdrawn

Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks

Role: collaborator

NCT02169726Completed

A Pilot Study Non-Invasive Guidance for Therapeutic Ultrasound Treatment of Lower Back Muscle Injuries

Role: collaborator

NCT00969397Phase 1Withdrawn

Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

Role: collaborator

NCT01485484Completed

Development and Validation of a NIRS-based Sinusitis Screening

Role: collaborator

NCT00544375Completed

Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in VLBW Infants Using Quantitative NIRS

Role: collaborator

NCT02051101Not ApplicableCompleted

Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples

Role: collaborator

NCT02178046Withdrawn

Non-Invasive Oral Biofilm Characterization

Role: collaborator

NCT01982357Completed

Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies

Role: collaborator